Board Appointment

Victrex PLC
03 July 2006

                                                                   3rd July 2006

                                  Victrex plc

                               BOARD APPOINTMENT


The Board of Victrex plc is pleased to announce the appointment of Giles Kerr BA
ACA as a non-executive director of the Company with effect from 1 August 2006.

Mr Kerr, aged 46, is currently the Finance Director of Oxford University and a
Fellow of Keble College, Oxford.  He was formerly with Amersham plc in a number
of senior management positions, most recently as Group Finance Director and was
previously a partner in Arthur Andersen.

Peter Warry, Chairman, said:

'I am very much looking forward to welcoming Giles to the Board.  His breadth of
experience, especially as Group Finance Director for Amersham plc, will
contribute significantly to Board debate.'

No further information in relation to Mr Kerr is required to be disclosed
pursuant to Listing Rule 9.6.13R.

As at 3 July 2006, Mr Kerr had no beneficial interest in the share capital of
the Company.


Enquiries

Victrex plc
Peter Warry, Chairman                                        01253 897700

Hogarth Partnership Limited
Nick Denton / Barnaby Fry                                    0207 357 9477


Victrex plc is an innovative, world leader in high performance materials through
the manufacture of VICTREX(R) PEEK(TM) polymer, a high performance, easy to
process thermoplastic.

VICTREX PEEK has a unique combination of chemical, wear, electrical, hydrolysis
and temperature resistance, as well as excellent dimensional, mechanical and
chemical stability combined with inherent purity and low flammability

End users specify VICTREX PEEK to reduce systems costs, improve part
performance, exploit greater design freedom and create a differentiated
application.  VICTREX PEEK is used across a broad range of applications in
diverse markets including transport, industrial, electronics and medical.
Invibio(R), Victrex's biomaterials business, provides specialised solutions for
medical device manufacturers.



                      This information is provided by RNS
            The company news service from the London Stock Exchange